Cargando…
Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report
The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with COVID-19 is supportive. The most severe patients need sustained life support for recovery. We herein describe the course of a critically ill COV...
Autores principales: | Huang, Thomas Tao-Min, Chien, Ying-Chun, Wang, Chih-Hsien, Chang, Sui-Yuan, Wang, Jann-Tay, Hsieh, Song-Chou, Yeh, Yu-Chang, Ku, Shih-Chi, Yu, Chong-Jen, Chiang, Bor-Luen, Chang, Shan-Chwen, Tolwani, Ashita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215202/ https://www.ncbi.nlm.nih.gov/pubmed/34164411 http://dx.doi.org/10.3389/fmed.2021.649583 |
Ejemplares similares
-
Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics
por: Liu, Wang-Da, et al.
Publicado: (2021) -
The role of phylogenetic analysis in clarifying the infection source of a COVID-19 patient
por: Wang, Jann-Tay, et al.
Publicado: (2020) -
Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit
por: Davenport, Andrew, et al.
Publicado: (2009) -
Preparedness of Kidney Replacement Therapy in the Critically Ill During COVID-19 Surge
por: Neyra, Javier A., et al.
Publicado: (2020) -
Impact of Prior Healthcare-Associated Exposure on Clinical and Molecular Characterization of Methicillin-Susceptible Staphylococcus aureus Bacteremia: Results From a Retrospective Cohort Study
por: Chen, Pao-Yu, et al.
Publicado: (2015)